Middle East War Spikes Global Oil and Diesel Prices
Saudi Arabia has delayed or canceled multiple crude shipments to European refiners after an attack damaged its East-West pipeline, with full restoration possibly taking up to six weeks. Brent crude has climbed above $105 per barrel, while U.S. diesel prices hit record highs above $6 per gallon. Houthi advances in Yemen further threaten Red Sea shipping, compounding earlier disruptions in the Strait of Hormuz. These supply shocks reverse a brief market reprieve and hit refined products hardest.
The pipeline carried an estimated 4-5 million barrels daily and served as a key alternative route. Seaborne storage has depleted, the U.S. Strategic Petroleum Reserve has drawn down significantly, and Russian refining capacity faces ongoing Ukrainian strikes. China has increased imports amid the tightness. Global South economies face acute pressure, as diesel powers transport, agriculture, and generators where infrastructure is weak; fertilizer prices are also rising due to Gulf sulfur disruptions.
Key uncertainties include whether half-capacity can resume quickly without further attacks, potential U.S. diesel export limits that risk higher gasoline prices, and the war’s unclear endgame. Farmers report daily cost spikes of up to $1,000, while political pressure mounts ahead of U.S. midterms. No coherent exit strategy is evident as costs cascade globally.
Sources: Responsible Statecraft, Naked Capitalism.
Congress Advances Sweeping Russia-Iran Sanctions Bill
The U.S. House passed the Lindsey O. Graham Sanctioning Russia and Iran Act by 262-159, sending it to President Trump after Senate approval. The measure targets Russian energy revenues funding the Ukraine war through primary and secondary sanctions on officials, oligarchs, banks, and the shadow fleet. It authorizes tariffs up to 100% on the top five buyers of Russian oil or gas, with limited exceptions, and extends Iran energy and weapons sanctions.
Named for the late senator who championed it, the bill overcame more than a year of delays and Democratic leadership opposition over expanded presidential tariff powers. Fifty-eight Democrats joined most Republicans in support; Ukrainian President Zelensky had lobbied for passage. Trump has signaled he will sign it soon.
Tensions center on whether tariffs will pressure China and India effectively or strain alliances, and if secondary measures disrupt global trade. Kremlin statements claim it complicates peace talks. Implementation timing and enforcement remain uncertain amid ongoing battlefield dynamics and U.S. domestic politics.
Sources: Naked Capitalism, Responsible Statecraft.
Drug Transparency Bill Weakened Before Senate Vote
The Clear Labels Act, aimed at revealing exact manufacturing sites of generic drugs on labels, advances to a full Senate vote after key provisions were stripped. Sponsors removed a unique FDA facility identifier code and extended vastavusnõuded from one year to five. Experts call it a clear watering-down that reduces traceability of factories linked to past quality lapses such as contamination.
The original bill responded to investigations showing continued U.S. imports from plants with documented safety failures that caused thousands of adverse reactions. Current labels often list only packagers, obscuring origins. Lawmakers cited price and national security concerns over revealing precise locations of lifesaving drugs.
Uncertainties include whether remaining address requirements will prove enforceable or allow loopholes via headquarters listings, and if the FDA can effectively oversee diluted rules. Industry lobbying opposed stronger measures; public health advocates argue the changes undermine the bill’s core purpose of consumer and doctor awareness.
Sources: ProPublica.